Sign in
4

Changes in Ownership

Traws Pharma, Inc. Filed Acc 0002018150-25-000004

Chief Science Officer Virology acquired 18,471 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Pauza Charles David · Chief Science Officer Virology

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-12 Grant or award : show line 1 in the form +18,471 115,971 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-12 Grant or award : show line 2 in the form Stock Option (right to purchase) +73,886 73,886 D
Loading xslF345X05/form4-12162025_111219.xml…